In a bleomycin-induced mouse model of lung fibrosis it was reported that pharmacological inhibition of DPP4 attenuated the development of lung fibrosis and reduced the expression of extracellular matrix proteins (Liu and Qi, 2020). This evidence concerns the gene DPP4 and pulmonary fibrosis.